Bora Pharmaceutical Services Inc.
73333 Mississauga Rd.
L5N 6L4 Canada
T: (866) 674-2762
Now employing over 900 people, the publicly listed (6472.TWO) Bora Pharmaceuticals is a premier, international, CGMP, CDMO specializing in complex oral solid dose (tablet, granules & capsules), liquids (solutions, suspensions, & nasal sprays) and semisolid (creams, lotions & gels) pharmaceutical Rx and OTC products for late-phase Clinical through Commercial manufacturing and packaging. Bora owns and operates three state-of-the-art CGMP manufacturing facilities in Taiwan and Canada that are built to the highest international standards for manufacturing, packaging, R&D, and analytical testing.
What makes us unique in solid dose is our ability to handle routine to complex solid dosage forms (tablet and capsules) including immediate release, controlled/extended release, extrusion/spheronization, beads, tray drying, solvent handling, film coating, Fluidized Coating System (Wurster), and much more. What makes us unique in semi-solids and liquids is our ability to manufacture from clinical to commercial scales with high throughput and our ability to handle solvents.
Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FA, and GCC (Gulf Cooperation Council) inspected. Our Canadian facility is approved by all major regulatory agencies including USFDA, Health Canada, ANVISA, EMA, PDMA. and the Japanese Ministry of Health. Our USFDA audits have had no major findings.
Our sites deliver to more than 100 markets around the world including the USA, Canada, EU, Southeast Asia, Middle East, and South and Central Americas.
Commercial & Clinical Manufacturing
Posted Date: 7/27/2021
This record has been viewed 1743 times.